Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Women’s Basketball Superstar Elena Delle Donne to be Honored at Lyme Research Alliance Gala on April 5
  • USA - English


News provided by

Lyme Research Alliance

Feb 26, 2014, 16:05 ET

Share this article

Share toX

Share this article

Share toX

Elena Delle Donne (credit NBA Photos)
Elena Delle Donne (credit NBA Photos)

Greenwich, CT (PRWEB) February 26, 2014 -- Lyme Research Alliance (LRA) today announced it will honor Elena Delle Donne—the reigning Women’s National Basketball Association’s (WNBA) Rookie of the Year—with its Star Light Award at LRA’s “Time for Lyme” Gala, on April 5, at the Hyatt Regency Greenwich in Old Greenwich, CT.

By sharing her story, Elena will be helping to educate countless Americans about the devastating impact of this disease.

Post this

“We are excited that Elena—one of the most talked-about women’s basketball players in the country—will be joining us at the Gala to receive this award,” said Ally Hilfiger, Event Chair. “More than 300,000 people are diagnosed every year with Lyme. By sharing her story and lending her name to LRA’s campaign to fund a cure, Elena will be helping to educate countless Americans about the devastating impact of this disease, including the financial hardships that come with the battle.”

Chicago Sky forward-guard Delle Donne, who was named to the All-WNBA Second Team and finished third overall in MVP voting in her rookie season, was sidelined twice by Lyme disease during her illustrious basketball career at the University of Delaware.

When she first contracted Lyme disease in 2008, Delle Donne had very little knowledge about the illness and 30 days of antibiotics knocked it out. But two years later, she experienced a severe recurrence. “At times, I was physically unable to get out of bed, suffered fatigue so extreme that I couldn’t lift my arm for more than 10 seconds, had migraine-like headaches, and felt like I was dying,” she said. “No doctor knew what it was.” But six weeks later, with the recurrence of Lyme diagnosed, the 6-foot-5-inch Delle Donne was able to return to the court in her senior season and lead her Delaware team to its most successful season ever.

Today Delle Donne, 24, says she wants to do all she can to raise awareness of the disease and speak to Lyme sufferers. “Not only are they going through physical and emotional challenges,” she said, “but the financial burden it brings to families is enormous. I hope I’ll be able to inspire people to not give up, especially those who are actively battling symptoms. I know how hard of a fight it is.”

In a wide-ranging interview with LRA, Delle Donne said that staying healthy is a daily battle for her. No longer on antibiotics, she takes “a lot” of vitamins and herbs, gets IV treatments, and goes regularly for massages. “I’m able to still be successful as long as I do my treatments and work with my doctor, but it’s been a very long road to establish my routine,” she said.

Delle Donne works out three hours daily and meets with a nutritionist to maintain her playing weight of 192 pounds. “I work out very hard—weight lifting, conditioning, playing basketball,” she told LRA. “I’m a perfectionist.”

Not only does Delle Donne want to be in peak health for the 34 games that the Chicago Sky play every season, but she also hopes to make the 2016 U.S. Summer Olympic team. However, Lyme disease is never far from her thoughts. “It’s a crazy illness and it’s always something I have to keep top of mind,” she said. “It’s important for anyone with Lyme to stick to their treatment, stay strong, and try not to let the disease take your life away.”

LRA’s “Time for Lyme” Gala, its largest fundraiser of the year, helps to fund important medical research projects. LRA is the leading private nonprofit organization funding cutting-edge research into the prevention, diagnosis and treatment of Lyme and other tick-borne diseases by universities and major medical institutions around the U.S.

The Gala is shaping up to be an exciting event with television personality Gretchen Carlson, herself a Lyme disease sufferer, serving as Mistress of Ceremonies. A veritable Who’s Who list of celebrities, including actor Peter Sarsgaard; baseball Hall of Famer Tom Seaver; actress Jane Alexander; Real Housewives of Beverly Hills co-star Yolanda Foster and others, have signed on as Honorary Event Chairs.

The Gala will be held Saturday, April 5 from 6:30 p.m. to midnight at the Hyatt Regency Greenwich in Old Greenwich, CT. It features dinner, dancing and a live auction.

Ticket Information
Tickets may be purchased online by visiting http://www.LymeResearchAlliance.org and clicking on the homepage box, or by calling 203-969-1333.

---

Lyme Research Alliance, formerly Time for Lyme, is a Connecticut-based, national non-profit that funds cutting-edge research into Lyme and other tick-borne diseases. For more information, go to http://www.LymeResearchAlliance.org.

Peter Wild, Lyme Research Alliance, http://www.lymeresearchalliance.org, +1 203-448-8801, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.